Bed, Bath and Beyond Hudson Comforter Recall Issued Due to Mold Risk

More than 175,000 comforters sold exclusively by Bed Bath & Beyond have been recalled, due to a risk that the bedding sets may grow mold, posing a risk of respiratory infections or adverse health reactions. 

The Bed Bath & Beyond recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on January 18, impacting Hudson comforters by Ugg.

The action was taken after the manufacturer found mold in several of the polyester comforter sets, which could pose a serious health risk for individuals with compromised immune systems, damaged lungs, or an allergy to mold.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Mold can cause a wide variety of symptoms such as sneezing, runny or stuffy nose, itchy eyes, throat and nose, but individuals with a mold allergy can be affected by much harsher symptoms. Those with mold allergies can experience wheezing, shortness of breath, and chest tightness that may develop into more severe conditions if the exposure is prolonged and left untreated.

The products being recalled are the Hudson comforters by Ugg that are made of polyester material and sold in either garnet, navy, gray or oatmeal colors. The products were sold in twin, full/queen and king sizes.

The recalled comforters were manufactured in China by BHF International LTD and distributed by Liberty Procurement Co., Inc. of Union, New Jersey, which is an affiliate of Bed Bath & Beyond Inc. The products were distributed for sale throughout the United States exclusively to Bed Bath & Beyond stores for in-store and online sales at www.bedbathandbeyond.com from August 2017 through October 2017 for about $70 (twin), $90 (full/queen), and $110 (king).

Approximately 175,000 units were distributed for sale throughout the United States and another 20 were sold in Canada.

Customers with recalled comforter sets should stop using them immediately and contact Bed Bath & Beyond at 800-462-3966 or visit them online at www.bedbathandbeyond.com and navigate to the “Product Recall Information” link at the bottom of the page for information on how to receive a full refund.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.